Andrew T Lenis

12PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Other creative arts and writing not elsewhere classifiedPredictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 17, 2026
A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin for the Treatment of Non-Muscle-Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder.

|Jan 10, 2025
Editorial Comment.

Srinath-Reddi Pingle, Andrew T Lenis

|Jul 01, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.

Andrew T Lenis, Vignesh Ravichandran, Samantha Brown

|May 01, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.

Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran

|Sep 08, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.

Brendan J Guercio, Michal Sarfaty, Min Yuen Teo

|Dec 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita

Pageof 2

Frequent Collaborators

6 joint publications

David B Solit

5 joint publications

Gopa Iyer

5 joint publications

Min Yuen Teo

5 joint publications

Dean F Bajorin